ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RTO Rentokil Initial Plc

471.70
-0.80 (-0.17%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rentokil Initial Plc LSE:RTO London Ordinary Share GB00B082RF11 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.80 -0.17% 471.70 471.70 472.00 474.60 471.80 474.60 9,406,710 16:35:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Disinfecting,pest Control Sv 5.38B 381M 0.1516 31.12 11.86B

Rentokil Initial PLC Q3 Interim Management Statement (4101W)

07/11/2014 7:00am

UK Regulatory


Rentokil Initial (LSE:RTO)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Rentokil Initial Charts.

TIDMRTO

RNS Number : 4101W

Rentokil Initial PLC

07 November 2014

RENTOKIL INITIAL PLC (RTO)

INTERIM MANAGEMENT STATEMENT

7 November 2014

 
  (GBPm)                            Q3 2014       Growth       YTD 2014       Growth 
                                      AER      AER      CER      AER       AER      CER 
 Revenue                             439.5    (3.4%)   3.3%     1,293.9   (4.1%)    2.1% 
 Revenue - ongoing operations(1)     439.5    (2.9%)   3.8%     1,293.0   (3.2%)    3.1% 
 Adjusted operating 
  profit(2)                          62.6     (4.1%)   4.0%       162.8   (1.9%)    6.2% 
 Adjusted profit before 
  tax(2)                             53.5      5.7%    15.4%      131.0     3.6%   14.1% 
 Profit before tax                   48.8     16.7%    27.0%      115.6    28.4%   42.0% 
---------------------------------  --------  -------  ------  ---------  -------  ------ 
 

Revenue (at CER)

Overall, revenue from ongoing operations increased by 3.8% in Q3 in line with Q2. Revenue grew organically by 1.1% and by 2.7% from businesses acquired in the last 12 months. Growth in Q3 in the Emerging (22.4%) and Growth (6.1%) quadrants was strong, partially offset by slight declines in the Protect and Enhance (-0.1%) and Manage for Value (-0.8%) quadrants. Divestments in the Manage for Value quadrant of our Belgian Flat Linen business and our Korean JV in 2013, and our Spanish Medical business in H1 2014, reduced revenue growth by 0.5% in Q3, resulting in total revenue growth in the quarter of 3.3%.

Profit (at CER)

Adjusted operating profit increased by 4.0% in Q3, reflecting growth in North America, Pacific and Germany, as well as lower overheads, partly offset by lower profits in Benelux and slower growth in France.

Adjusted profit before tax at actual exchange rates continues to be negatively impacted by the continued strengthening of Sterling. Based on current exchange rates the impact of currency movements would be around GBP17m for the full year, in line with our previous guidance.

Reorganisation costs and one-off items for continuing operations were significantly lower in Q3 at GBP0.1m versus GBP5.5m last year, contributing to an increase in profit before tax of 27.0% in the quarter. After taking into account currency movements, profit before tax at AER increased by 16.7%. We now expect reorganisation costs and one-off items to be less than GBP10m for the year.

Cash flow and interest costs

Operating and free cash flow continue to be strong and we remain on track to achieve our targets for the year. During the quarter we took advantage of an invoice factoring exercise in our French business which is anticipated to increase working capital inflows by approximately GBP15m. With our improved net debt position we now expect interest costs to be in the region of GBP47m (at CER) for the year compared to the previous guidance of GBP50m.

M&A

We acquired 5 businesses in the quarter and have now acquired 18 businesses in pest control in the year along with one small acquisition in hygiene and three in plants. Combined annual revenues of the above businesses totalled GBP40m in the 12 months immediately prior to acquisition.

Commenting on the Q3 results Andy Ransom, CEO of Rentokil Initial plc, said:

"I am pleased to report that the business maintained the recent level of revenue growth in the quarter with the Pest Control category continuing to perform well in our Emerging and Growth quadrants. Challenging trading conditions persist in our European businesses, impacting our hygiene and workwear categories in our Protect & Enhance and Manage for Value quadrants.

"Profit growth in the quarter continues to reflect the benefit of more efficient businesses and reduced overheads and has been achieved despite the challenging European trading conditions. We continue to execute our strategy at pace, to drive improved revenue, profit and cash, and we expect Q4 operating performance to be in line with Q3."

Enquiries:

Investors / Analysts: Guy Smith Rentokil Initial plc 01276 536585/07879 662664

Media: Malcolm Padley Rentokil Initial plc 07788 978 199

                                              Justine McIllroy                Brunswick Group           020 7404 5959 

Nina Coad

Oliver Hughes

A call for investors and analysts will be held on Friday 7 November at 9.15am:

Participant Details:

   London, UK:                     +44(0)203 427 1912 
   Paris, France:                  +33(0)1 76 77 22 20 
   Hong Kong:                      +852 3002 1615 
   New York, USA:              +1 646 254 3362 
   Participant PIN code:        7321731# 

Playback Details (available for 14 days):

   London, UK:                     +44(0)203 427 0598 
   Paris, France:                  +33(0)1 74 20 28 00 
   Hong Kong:                      +852 3011 4669 
   New York, USA:              +1 347 366 9565 
   Playback PIN code:          7321731# 

AER - actual exchange rates; CER - constant 2013 exchange rates

(1) ongoing revenue represents revenue with disposals removed and includes revenue from acquisitions.

(2) before amortisation and impairment of intangibles (excluding computer software), reorganisation costs and one-off items, and net interest credit from pensions

This announcement contains statements that are, or may be, forward-looking regarding the group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS

The company news service from the London Stock Exchange

END

IMSUNRWRSBAARAA

1 Year Rentokil Initial Chart

1 Year Rentokil Initial Chart

1 Month Rentokil Initial Chart

1 Month Rentokil Initial Chart

Your Recent History

Delayed Upgrade Clock